Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants

Journal of Pediatrics

Volumn 195, Issue , 2018, Pages 73-79.e2

  Kane, Andrea F ^a,b   Bhatia, Anisha D ^a,b,c   Denning, Patricia W ^a,b   Shane, Andi L ^a,b   Patel, Ravi Mangal ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

^c UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

bacteria; microbiome; morbidity; neonate; preterm; probiotic

Indexed keywords

ANTIBIOTIC AGENT; INDOMETACIN; INOTROPIC AGENT; PROBIOTIC AGENT; STEROID;

ANTIBIOTIC THERAPY; ARTICLE; BREAST MILK; COHORT ANALYSIS; ERYTHROCYTE TRANSFUSION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; LACTOBACILLUS RHAMNOSUS; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROCESS CONTROL; RETROSPECTIVE STUDY; SMALL FOR DATE INFANT; VERY LOW BIRTH WEIGHT; NEWBORN; RISK FACTOR; STATISTICAL MODEL;

ENTEROCOLITIS, NECROTIZING; FEMALE; GESTATIONAL AGE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LACTOBACILLUS RHAMNOSUS; LOGISTIC MODELS; MALE; PROBIOTICS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 85041583306     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2017.11.055     Document Type: Article

References (23)

1. Lin, P.W., Stoll, B.J., Necrotizing enterocolitis. Lancet 368 (2006), 1271–1283.
2. Neu, J., Walker, W.A., Necrotizing enterocolitis. N Engl J Med 364 (2011), 255–264.
3. Frost, B.L., Modi, B.P., Jaksic, T., Caplan, M.S., New medical and surgical insights into neonatal necrotizing enterocolitis: a review. JAMA Pediatr 171 (2017), 83–88.
4. Horbar, J.D., Edwards, E.M., Greenberg, L.T., Morrow, K.A., Soll, R.F., Buus-Frank, M.E., et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr, 171, 2017, e164396.
5. Sawh, S.C., Deshpande, S., Jansen, S., Reynaert, C.J., Jones, P.M., Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis. Peer J, 4, 2016, e2429.
6. Viswanathan, S., Lau, C., Akbari, H., Hoyen, C., Walsh, M.C., Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States. J Perinatol 36 (2016), 1106–1111.
7. von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C., Vandenbroucke, J.P., et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335 (2007), 806–808.
8. Walsh, M.C., Kliegman, R.M., Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33 (1986), 179–201.
9. Olsen, I.E., Groveman, S.A., Lawson, M.L., Clark, R.H., Zemel, B.S., New intrauterine growth curves based on United States data. Pediatrics 125 (2010), e214–e224.
10. Samuels, N., van de Graaf, R.A., de Jonge, R.C.J., Reiss, I.K.M., Vermeulen, M.J., Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies. BMC Pediatr, 17, 2017, 105.
11. Patel, R.M., Denning, P.W., Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?. Clin Perinatol 40 (2013), 11–25.
12. Dani, C., Coviello, C.C., Corsini, I.I., Arena, F., Antonelli, A., Rossolini, G.M., Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review. AJP Rep 6 (2016), e25–e29.
13. Patel, R.M., Kandefer, S., Walsh, M.C., Bell, E.F., Carlo, W.A., Laptook, A.R., et al. Causes and timing of death in extremely premature infants from 2000 through 2011. N Engl J Med 372 (2015), 331–340.
14. Ahle, M., Drott, P., Andersson, R.E., Epidemiology and trends of necrotizing enterocolitis in Sweden: 1987-2009. Pediatrics 132 (2013), e443–e451.
15. Heida, F.H., Stolwijk, L., Loos, M.H., van den Ende, S.J., Onland, W., van den Dungen, F.A., et al. Increased incidence of necrotizing enterocolitis in the Netherlands after implementation of the new Dutch guideline for active treatment in extremely preterm infants: results from three academic referral centers. J Pediatr Surg 52 (2017), 273–276.
16. Lewis, Z.T., Shani, G., Masarweh, C.F., Popovic, M., Frese, S.A., Sela, D.A., et al. Validating bifidobacterial species and subspecies identity in commercial probiotic products. Pediatr Res 79 (2016), 445–452.
17. Vallabhaneni, S., Walker, T.A., Lockhart, S.R., Ng, D., Chiller, T., Melchreit, R., et al. Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement–Connecticut, 2014. MMWR Morb Mortal Wkly Rep 64 (2015), 155–156.
18. Manzoni, P., Lista, G., Gallo, E., Marangione, P., Priolo, C., Fontana, P., et al. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev 87:Suppl 1 (2011), S35–S38.
19. Bonsante, F., Iacobelli, S., Gouyon, J.B., Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol 30 (2013), 41–46.
20. Al-Hosni, M., Duenas, M., Hawk, M., Stewart, L.A., Borghese, R.A., Cahoon, M., et al. Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 32 (2012), 253–259.
21. Costeloe, K., Hardy, P., Juszczak, E., Wilks, M., Millar, M.R., Probiotics in Preterm Infants Study Collaborative Group. Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387 (2016), 649–660.
22. Jacobs, S.E., Tobin, J.M., Opie, G.F., Donath, S., Tabrizi, S.N., Pirotta, M., et al. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 132 (2013), 1055–1062.
23. Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., et al. The “Golden Age” of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants. Neonatology 112 (2017), 9–23.